Your browser doesn't support javascript.
Mental Health During COVID-19 Lockdown in the United Kingdom.
Pieh, Christoph; Budimir, Sanja; Delgadillo, Jaime; Barkham, Michael; Fontaine, Johnny R J; Probst, Thomas.
  • Pieh C; From the Department for Psychotherapy and Biopsychosocial Health (Pieh, Budimir, Probst), Danube University Krems, Krems an der Donau, Austria; Clinical Psychology Unit, Department of Psychology (Delgadillo, Barkham), University of Sheffield, Sheffield, United Kingdom; and Department of Work, Organization and Society (Budimir, Fontaine), Ghent University, Ghent, Belgium.
Psychosom Med ; 83(4): 328-337, 2021 05 01.
Article in English | MEDLINE | ID: covidwho-1218022
ABSTRACT

OBJECTIVE:

The coronavirus disease (COVID-19) pandemic and related lockdown measures have raised important questions about the impact on mental health. This study evaluated several mental health and well-being indicators in a large sample from the United Kingdom (UK) during the COVID-19 lockdown where the death rate is currently among the highest in Europe.

METHODS:

A cross-sectional online survey with a study sample that mirrors general population norms according to sex, age, education, and region was launched 4 weeks after lockdown measures were implemented in the UK. Measures included mental health-related quality of life (World Health Organization Quality-of-Life Brief Version psychological domain), well-being (World Health Organization Well-Being Index), depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder-7), perceived stress (Perceived Stress Scale-10), and insomnia (Insomnia Severity Index). Analyses of variances, Bonferroni-corrected post hoc tests, and t tests were applied to examine mental health indicators across different sociodemographic groups (age, sex, employment, income, physical activity, relationship status).

RESULTS:

The sample comprised n = 1006 respondents (54% women) from all regions of the UK. Approximately 52% of respondents screened positive for a common mental disorder, and 28% screened positive for clinical insomnia. Mean scores and standard deviations were as follows Patient Health Questionnaire-9, mean = 9.0 ± 7.7; Generalized Anxiety Disorder-7, mean = 8.0 ± 6.5; Insomnia Severity Index, mean = 10.4 ± 7.0; Perceived Stress Scale-10, mean = 17.7 ± 7.9; World Health Organization Quality-of-Life Brief Version, mean = 58.6 ± 21.4; and World Health Organization Well-Being Index score, mean = 13.0 ± 6.0. Statistical analyses consistently indicated more severe mental health problems in adults younger than 35 years, women, people with no work, and people with low income (all p values < .05). Mental health indices also varied across UK regions.

CONCLUSIONS:

The prevalence of depressive, anxiety, and insomnia symptoms is significantly higher in the UK relative to prepandemic epidemiological data. Further studies are needed to clarify the causes for these high rates of mental health symptoms.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Disease Control / Mental Health / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Psychosom Med Year: 2021 Document Type: Article Affiliation country: PSY.0000000000000871

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Disease Control / Mental Health / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: Psychosom Med Year: 2021 Document Type: Article Affiliation country: PSY.0000000000000871